glutamine has been researched along with Cortical Lewy Body Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Cheng, JY; Deng, YT; Yu, JT | 1 |
Beach, TG; Bluhm, A; Coras, R; Hartlage-Rübsamen, M; Hilbrich, I; Holzer, M; Köppen, J; Machner, L; Moceri, S; Richter, F; Roßner, S; Schenk, M; Schilling, S; Schulze, A; Serrano, GE; von Hörsten, S; Weidenfeller, M; Xiang, W | 1 |
Blamire, AM; Hayes, L; He, J; O'Brien, JT; Su, L; Watson, R | 1 |
3 other study(ies) available for glutamine and Cortical Lewy Body Disease
Article | Year |
---|---|
The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.
Topics: Alzheimer Disease; Amino Acids; Causality; Genome-Wide Association Study; Glutamine; Humans; Lewy Body Disease; Mendelian Randomization Analysis; Neurodegenerative Diseases; Parkinson Disease | 2023 |
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
Topics: alpha-Synuclein; Aminoacyltransferases; Animals; Brain; Cell Survival; Chromatography, Gel; Dopaminergic Neurons; Glutamine; Humans; Kinetics; Lewy Body Disease; Mice; Mice, Transgenic; Parkinson Disease; Protein Processing, Post-Translational; Sambucus nigra; Synucleinopathies | 2021 |
Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Brain; Case-Control Studies; Choline; Creatine; Female; Glutamic Acid; Glutamine; Humans; Inositol; Lewy Body Disease; Magnetic Resonance Imaging; Male; Proton Magnetic Resonance Spectroscopy | 2016 |